[1] 世界卫生组织. 2019冠状病毒病(COVID-19)及其病毒的命名[EB/OL]. (2020-02-12) [2020-03-04]. https://www.who.int/zh/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-i. [2] 国家卫生健康委.新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL]. (2020-03-04) [2020-03-04]. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml. [3] 田地,王琳,葛子若, 等. 新型冠状病毒肺炎抗病毒治疗现状及前景[J]. 中国药物警戒, 2020, 17(3):129-135. [4] 世界卫生组织.艾滋病毒/艾滋病[EB/OL]. (2019-11-28)[2020-03-04]. https://www.who.int/zh/news-room/fact-sheets/detail/hiv-aids. [5] 马奇三, 王正平, 李金亮, 等. 抗艾滋病药物的现状与挑战[J].聊城大学学报(自然科学版), 2020, 33(1):70-78. [6] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2):145-151. [7] 胡仁明, 李益明, 童伟. 哈里森内分泌学[M].北京:人民卫生出版社, 2010:8. [8] Samaha FF, Ky B, Lo Re V 3rd. Type III hyperlipoproteinemia unmasked by HIV anti-retroviral therapy[J]. Am J Med, 2005,118(6):691-692. [9] Mcarthur MA, Kalu SU, Foulks AR, et al.Twin preterm neonates with cardiac toxicity related to Lopinavir/Ritonavir therapy[J].Pediatr Infect Dis J, 2009, 28(12):1127-1129. [10] Chaubey SK, Sinha AK, Phillips E, et al.Transient cardiac arrhythmias related to Lopinavir/Ritonavir in two patients with HIV infection[J]. Sex Health, 2009, 6(3):254-257. [11] Deeks SG, Gandhi RT, Chae CU, et al.Case Records of the Massa-chusetts General Hospital. Case 30-2012. A 54-year-old Woman With HIV Infection, Dyspnea, and Chest Pain[J]. N Engl J Med,2012,367(13):1246-1254. [12] 姚亚敏, 沐俊, 孙骥, 等. 洛匹那韦药代动力学的研究进展[J].药学实践杂志,2012,30(5):336-339. [13] Lawson E, Bond K, Churchill D, et al.A case of immune recon-stitution syndrome: adult-onset Still's disease in a patient with HIV infection[J]. Rheumatology (Oxford), 2009, 48(4):446-467. [14] Sheehan NL, Brouillette MJ, Delisle MS, et al.Possible intera- ction between Lopinavir/Ritonavir and valproic Acid exacerbates bipolar disorder[J]. Ann Pharmacother, 2006, 40(1):147-150. [15] Puech R, Gagnieu MC, Planus C, et al.Extreme bradycardia due to multiple drug-drug interactions in a patient with HIV post-exposure prophylaxis containing lopinavir-ritonavir[J]. Br J Clin Pharmacol, 2011, 71(4):621-623. [16] 刘百义, 秦荣新, 梁健成, 等. 门诊艾滋病患者处方点评和药物相互作用分析[J]. 中国药房, 2015, 26(2):153-155. |